Dr Reddys Laboratories Ltd Share Price Today - Live Blog for January 01, 2026

Dr Reddys Laboratories Ltd's share price has fallen by -1.37%, presenting both challenges and opportunities for investors. As of now, it's trading at 1254.00, and market participants are assessing the implications. The stock has a PE ratio of 18.4900, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd has plummeted by -1.37%, signalling a challenging period. Currently trading at 1254.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

With a -1.60% decrease, Dr Reddys Laboratories Ltd's share price is now 1251.00. Investors should examine the factors driving this decline. The stock's PE ratio is 18.4900, whereas the industry PE ratio stands at 33.2247.

Dr Reddys Laboratories Ltd shares experienced a -1.61% reduction, with the current market price at 1250.90. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The stock of Dr Reddys Laboratories Ltd has experienced a -1.47% drop, and it's now trading at 1252.70 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd experienced a -1.31% downturn in its share price, and it's currently trading at 1254.80. This situation is generating interest among value investors who are evaluating the stock's potential.

With a -1.30% decrease, Dr Reddys Laboratories Ltd's share price is currently at 1254.90. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.4900, while the industry PE is 33.2247.